These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10933045)

  • 1. Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.
    Sood AK; Sorosky JI; Squatrito RC; Skilling JS; Anderson B; Buller RE
    Neoplasia; 1999 Jun; 1(2):118-22. PubMed ID: 10933045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients.
    Chambers SK; Davis CA; Chambers JT; Schwartz PE; Lorber MI; Hschumacher RE
    Clin Cancer Res; 1996 Oct; 2(10):1699-704. PubMed ID: 9816119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.
    Chambers SK; Davis CA; Schwartz PE; Kohorn EI; Chambers JT
    Clin Cancer Res; 1996 Oct; 2(10):1693-7. PubMed ID: 9816118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Criteria for the determination of the immediate efficacy of chemotherapy in gynecologic neoplasms].
    Koto T; Tsunawaki A
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):4262-76. PubMed ID: 3729501
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A Gynecologic Oncology Group Study.
    Manetta A; Boyle J; Berman ML; DiSaia PJ; Lentz S; Liao SY; Mutch D; Slater L
    Cancer; 1994 Jan; 73(1):196-9. PubMed ID: 8275425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gynecologic Oncology Group experience with ifosfamide.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):6-10. PubMed ID: 2159188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate with leucovorin rescue in the treatment of gynecologic malignancies. Preliminary report.
    Corder MP; Hively LF; Stone WH; Flannery EP; Justice GR
    Oncology; 1975; 32(5-6):275-82. PubMed ID: 180471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of m-AMSA in the treatment of advanced gynecologic malignancies.
    Brenner DE; Garbino C; Kasdorf H; Villasanta U; Polcaro R; Yovarone J; Aisner J; Schiffer CA; Wiernik PH
    Am J Clin Oncol; 1982 Jun; 5(3):291-5. PubMed ID: 6896260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologic malignancies.
    Schaebler DL; Schilder RJ; Young RC
    Cancer Chemother Biol Response Modif; 1994; 15():555-80. PubMed ID: 7779599
    [No Abstract]   [Full Text] [Related]  

  • 11. Gynecologic Oncology Group studies with ifosfamide.
    Sutton GP; Blessing JA; Manetta A; Homesley H; McGuire W
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):31-4. PubMed ID: 1485172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cisplatin and cyclosporin A in recurrent platinum-resistant ovarian cancer: a phase II study of the gynecologic oncology group.
    Manetta A; Blessing JA; Hurteau JA
    Gynecol Oncol; 1998 Jan; 68(1):45-6. PubMed ID: 9454659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of gynecologic neoplasms in internal medicine].
    Mayr AC
    Schweiz Med Wochenschr; 1978 Sep; 108(35):1369-73. PubMed ID: 80032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
    Shimizu Y
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):431-8. PubMed ID: 9063480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliation chemotherapy of pelvic carcinoma by systemic, perfusion, and infusion modalities.
    Boutselis JG; Ullery JC; Pace W
    Ohio State Med J; 1971 Aug; 67(8):721-5. PubMed ID: 4105456
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of liposomal doxorubicin in advanced gynecologic cancers.
    Israel VP; Garcia AA; Roman L; Muderspach L; Burnett A; Jeffers S; Muggia FM
    Gynecol Oncol; 2000 Aug; 78(2):143-7. PubMed ID: 10926793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
    Senapad S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):656-9. PubMed ID: 3939044
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V
    Med Welt; 1967 Oct; 42():2498-501. PubMed ID: 4306391
    [No Abstract]   [Full Text] [Related]  

  • 19. [A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer. Research Groups of CPT-11 in Gynecologic Cancers].
    Takeuchi S; Dobashi K; Fujimoto S; Tanaka K; Suzuki M; Terashima Y; Hasumi K; Akiya K; Negishi Y; Tamaya T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1681-9. PubMed ID: 1872624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ifosfamide combination chemotherapy for advanced gynecologic malignancies].
    Li X; Liu L; Wu L
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):330-2. PubMed ID: 11778564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.